Lenalidomide/anthracyclines/alkylating-agentsAcute myeloid leukaemia and myelodysplastic neoplasms

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-024-54526-2
中图分类号
学科分类号
摘要
引用
收藏
页码:217 / 217
相关论文
共 50 条
  • [21] Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
    Divoux, Marion
    Plocque, Alexia
    Sevin, Margaux
    Voillat, Laurent
    Feugier, Pierre
    Guerci-Bresler, Agnes
    Girodon, Francois
    Broseus, Julien
    CLINICAL CASE REPORTS, 2020, 8 (09): : 1774 - 1780
  • [23] A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia
    Perez, A
    Kennedy, C
    Standen, G
    Oxley, J
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (05) : 497 - 498
  • [26] IRREVERSIBLE LENALIDOMIDE RELATED OPTIC NEUROPATHY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA
    Cheng, Yen
    Aujla, Jaskirat
    Simon, Sumu
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 115 - 116
  • [27] ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia
    N Otto
    G Manukjan
    G Göhring
    W Hofmann
    R Scherer
    J Chacon Luna
    U Lehmann
    A Ganser
    K Welte
    B Schlegelberger
    D Steinemann
    Leukemia, 2011, 25 : 1202 - 1207
  • [28] Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome
    Iacobucci, Ilaria
    Mullighan, Charles G.
    CURRENT OPINION IN HEMATOLOGY, 2021, 28 (02) : 101 - 109
  • [29] Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes
    deGreef, GE
    Hagemeijer, A
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (01): : 1 - 18